Mersana Therapeutics (MRSN) delivered earnings and revenue surprises of -4.86% and -18.85%, respectively, for the quarter ended September 2025. Do the...
Vous n'êtes pas connecté
Maroc - ZACKS.COM - All Stories - 13/Nov 14:40
Fate Therapeutics (FATE) delivered earnings and revenue surprises of +6.90% and +104.82%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Mersana Therapeutics (MRSN) delivered earnings and revenue surprises of -4.86% and -18.85%, respectively, for the quarter ended September 2025. Do the...
Mersana Therapeutics (MRSN) delivered earnings and revenue surprises of -4.86% and -18.85%, respectively, for the quarter ended September 2025. Do the...
Canaan (CAN) delivered earnings and revenue surprises of +16.67% and +19.26%, respectively, for the quarter ended September 2025. Do the numbers hold...
HeartCore Enterprises (HTCR) delivered earnings and revenue surprises of -500.00% and +19.34%, respectively, for the quarter ended September 2025. Do...
HeartCore Enterprises (HTCR) delivered earnings and revenue surprises of -500.00% and +19.34%, respectively, for the quarter ended September 2025. Do...
Nyxoah (NYXH) delivered earnings and revenue surprises of -21.31% and +18.02%, respectively, for the quarter ended September 2025. Do the numbers hold...
Nyxoah (NYXH) delivered earnings and revenue surprises of -21.31% and +18.02%, respectively, for the quarter ended September 2025. Do the numbers hold...
Luminar Technologies (LAZR) delivered earnings and revenue surprises of +10.48% and +2.01%, respectively, for the quarter ended September 2025. Do the...
Luminar Technologies (LAZR) delivered earnings and revenue surprises of +10.48% and +2.01%, respectively, for the quarter ended September 2025. Do the...
Rekor Systems (REKR) delivered earnings and revenue surprises of +40.00% and +1.39%, respectively, for the quarter ended September 2025. Do the...